Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa

Hefei Zhang, Mark Schmidt, Daryl J Murry, Maureen D. Donovan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Baclofen, an antispasmodic agent that acts as a GABAB agonist, resembles phenylalanine in structure and has been reported to be a substrate of the large amino acid transporter 1 (LAT-1). The objective of this study was to investigate the absorption of baclofen across the nasal mucosa both in vitro and in vivo. Baclofen transport was measured across excised bovine olfactory and respiratory mucosae to investigate site-specific uptake of baclofen, and the intranasal bioavailability of R- and S-baclofen was determined in rats. Increasing flux with increasing baclofen donor concentration and the absence of polarized transport was observed in vitro, and similar distribution profiles were observed for both enantiomers following intranasal administration in rats. The absence of stereospecificity in nasal absorption indicates limited involvement of the amino acid or other transporters in the nasal absorption of baclofen.

Original languageEnglish (US)
Pages (from-to)2717-2723
Number of pages7
JournalJournal of Pharmaceutical Sciences
Volume100
Issue number7
DOIs
StatePublished - Jan 1 2011

Fingerprint

Baclofen
Nasal Mucosa
Amino Acid Transport System L
Intranasal Administration
Olfactory Mucosa
Respiratory Mucosa
Parasympatholytics
Physiological Absorption
Phenylalanine
Biological Availability
Amino Acids

Keywords

  • Bioavailability
  • Nasal absorption
  • Nasal drug delivery
  • Permeability
  • Pharmacokinetics
  • Transporters

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa. / Zhang, Hefei; Schmidt, Mark; Murry, Daryl J; Donovan, Maureen D.

In: Journal of Pharmaceutical Sciences, Vol. 100, No. 7, 01.01.2011, p. 2717-2723.

Research output: Contribution to journalArticle

Zhang, Hefei ; Schmidt, Mark ; Murry, Daryl J ; Donovan, Maureen D. / Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa. In: Journal of Pharmaceutical Sciences. 2011 ; Vol. 100, No. 7. pp. 2717-2723.
@article{d6c5c29ecf1046ccb4736a0a9078bfce,
title = "Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa",
abstract = "Baclofen, an antispasmodic agent that acts as a GABAB agonist, resembles phenylalanine in structure and has been reported to be a substrate of the large amino acid transporter 1 (LAT-1). The objective of this study was to investigate the absorption of baclofen across the nasal mucosa both in vitro and in vivo. Baclofen transport was measured across excised bovine olfactory and respiratory mucosae to investigate site-specific uptake of baclofen, and the intranasal bioavailability of R- and S-baclofen was determined in rats. Increasing flux with increasing baclofen donor concentration and the absence of polarized transport was observed in vitro, and similar distribution profiles were observed for both enantiomers following intranasal administration in rats. The absence of stereospecificity in nasal absorption indicates limited involvement of the amino acid or other transporters in the nasal absorption of baclofen.",
keywords = "Bioavailability, Nasal absorption, Nasal drug delivery, Permeability, Pharmacokinetics, Transporters",
author = "Hefei Zhang and Mark Schmidt and Murry, {Daryl J} and Donovan, {Maureen D.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1002/jps.22499",
language = "English (US)",
volume = "100",
pages = "2717--2723",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa

AU - Zhang, Hefei

AU - Schmidt, Mark

AU - Murry, Daryl J

AU - Donovan, Maureen D.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Baclofen, an antispasmodic agent that acts as a GABAB agonist, resembles phenylalanine in structure and has been reported to be a substrate of the large amino acid transporter 1 (LAT-1). The objective of this study was to investigate the absorption of baclofen across the nasal mucosa both in vitro and in vivo. Baclofen transport was measured across excised bovine olfactory and respiratory mucosae to investigate site-specific uptake of baclofen, and the intranasal bioavailability of R- and S-baclofen was determined in rats. Increasing flux with increasing baclofen donor concentration and the absence of polarized transport was observed in vitro, and similar distribution profiles were observed for both enantiomers following intranasal administration in rats. The absence of stereospecificity in nasal absorption indicates limited involvement of the amino acid or other transporters in the nasal absorption of baclofen.

AB - Baclofen, an antispasmodic agent that acts as a GABAB agonist, resembles phenylalanine in structure and has been reported to be a substrate of the large amino acid transporter 1 (LAT-1). The objective of this study was to investigate the absorption of baclofen across the nasal mucosa both in vitro and in vivo. Baclofen transport was measured across excised bovine olfactory and respiratory mucosae to investigate site-specific uptake of baclofen, and the intranasal bioavailability of R- and S-baclofen was determined in rats. Increasing flux with increasing baclofen donor concentration and the absence of polarized transport was observed in vitro, and similar distribution profiles were observed for both enantiomers following intranasal administration in rats. The absence of stereospecificity in nasal absorption indicates limited involvement of the amino acid or other transporters in the nasal absorption of baclofen.

KW - Bioavailability

KW - Nasal absorption

KW - Nasal drug delivery

KW - Permeability

KW - Pharmacokinetics

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=79955601355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955601355&partnerID=8YFLogxK

U2 - 10.1002/jps.22499

DO - 10.1002/jps.22499

M3 - Article

VL - 100

SP - 2717

EP - 2723

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 7

ER -